1 / 10

MERS- CoV in KSA

MERS- CoV in KSA. Bashaer Mohammedsaleh. What is it?. Middle East Respiratory Syndrome Coronavirus . Causes Respiratory failure With small number of reported cases, info about transmission, severity, clinical impact. Extraordinary large RNA virus. A syndrome means it’s progressive. .

liesel
Download Presentation

MERS- CoV in KSA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MERS-CoV in KSA BashaerMohammedsaleh

  2. What is it? • Middle East Respiratory Syndrome Coronavirus. • Causes Respiratory failure • With small number of reported cases, info about transmission, severity, clinical impact. • Extraordinary large RNA virus. • A syndrome means it’s progressive.

  3. Incidents • Starting June 2012 the 1st patient (Saudi) was identified with it. • 60 cases of deaths globally out of 138, 40 of which are Saudis or in SA. • Mortality 60%

  4. Symptoms • Similar to any respiratory disease e.g. common flu: • Cough and/or sneezing • Fever • Shortness of breath • Headache • Diarrhea and/ or vomiting • Dizziness

  5. MERS-CoV VS SARS • Severe Acute Respiratory Syndrome, caused by SARS-CoV. • breakage in 2003, in China- Guangdong • 1st host are civets, then humans. • 778 deaths out of 8098 infected patients. • Same symptoms, same incubation period (~12d) • Later respiratory failure (5d later). • Treated with O2 supplement, corticosteroids, and ribavirin.

  6. Less medical personnel infected. • Witnessed of person to person transmission, though with no clear evidence or basis. • Infected person seems with be personally close to patient. • Ribavirinand Interferon aren’t of much benefit. • Host camels (Oman, Canary Islands, and Egypt) and bats (Bisha, SA). • 24% of cases and nosocomial --of hospital origin.

  7. Current treatment/ contamination • Isolate patients, patient-to-medical personnel infection. • Treatment of evident symptoms. • No cure/ vaccine. • Influenza and Pneumococcal vaccinations recommended for ME travelers.

  8. prevention • Like all air-transmitted diseases:- the point is to keep sneezed or coughed water droplet min. in breathed air and, min. contact with those contaminated with them. • Washing hands properly with soap often. • Sneezing and coughing on a paper tissue and dispose it.

  9. Government efforts with hajj season • Hygiene promoting brochures: wash hands, avoid direct sun exposure, don’t share personal items… • Over 337000 medical employee and volunteers in the season, present in pilgrimage site. • Medical care is free of charge. • Recommendations for those with higher risk of infection to post-pone it: pregnant ladies, children, elders >56y.

  10. References: • WHO website: http://www.who.int/csr/disease/coronavirus_infections/en/ • Saudi Ministry of Health website: http://www.moh.gov.sa/en/Hajj/Pages/default.aspx • http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(13)70193-2/fulltext • http://www.ecdc.europa.eu/en/publications/publications/rra_mers-cov_7th_update.pdf

More Related